Covered recipient · General Payments record
NIDHI SETHI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,714.16
- Reported across 147 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $660.00 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $228.57 | 13 |
| PFIZER INC. | $116.05 | 6 |
| EMD Serono, Inc. | $51.30 | 2 |
| Lilly USA, LLC | $48.82 | 2 |
| UCB, Inc. | $42.40 | 2 |
| Amneal Pharmaceuticals LLC | $42.14 | 2 |
| ARGENX US, INC. | $36.32 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.73 | 1 |
| Teva Pharmaceuticals USA, Inc. | $23.05 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.68 | 1 |
| SCILEX PHARMACEUTICALS INC. | $14.66 | 1 |
| Amgen Inc. | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.71 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175162 | CMS |
| ABBVIE INC. | $15.87 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175164 | CMS |
| ABBVIE INC. | $26.20 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175166 | CMS |
| ABBVIE INC. | $16.50 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175168 | CMS |
| ABBVIE INC. | $6.44 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175170 | CMS |
| ABBVIE INC. | $23.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175172 | CMS |
| ABBVIE INC. | $31.79 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175174 | CMS |
| ABBVIE INC. | $15.19 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175176 | CMS |
| ABBVIE INC. | $18.12 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175178 | CMS |
| ABBVIE INC. | $23.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175180 | CMS |
| ABBVIE INC. | $12.19 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175182 | CMS |
| ABBVIE INC. | $3.88 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175184 | CMS |
| ABBVIE INC. | $13.64 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175186 | CMS |
| Amgen Inc. | $14.28 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117379274 | CMS |
| Amneal Pharmaceuticals LLC | $22.14 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216640 | CMS |
| Amneal Pharmaceuticals LLC | $20.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139216642 | CMS |
| ARGENX US, INC. | $18.16 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142148299 | CMS |
| ARGENX US, INC. | $18.16 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142149196 | CMS |
| EMD Serono, Inc. | $26.16 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120257964 | CMS |
| EMD Serono, Inc. | $25.14 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120265933 | CMS |
| Lilly USA, LLC | $24.41 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920064 | CMS |
| Lilly USA, LLC | $24.41 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920066 | CMS |
| Novartis Pharmaceuticals Corporation | $25.73 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087200027 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.68 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119183182 | CMS |
| PFIZER INC. | $18.79 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130927024 | CMS |
| PFIZER INC. | $15.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130927479 | CMS |
| PFIZER INC. | $23.05 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130927845 | CMS |
| PFIZER INC. | $16.08 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130927385 | CMS |
| PFIZER INC. | $19.46 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130929914 | CMS |
| PFIZER INC. | $22.97 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130955804 | CMS |
| SCILEX PHARMACEUTICALS INC. | $14.66 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136272657 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.05 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151479980 | CMS |
| UCB, Inc. | $17.32 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143491178 | CMS |
| UCB, Inc. | $25.08 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143491184 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.